{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T08:00:28Z","timestamp":1758268828286,"version":"3.37.3"},"reference-count":7,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,16]]},"abstract":"<jats:p>We provide patient and clinician perspectives on the dermatological outcomes of patients with neurofibromatosis type 1 (NF1) seeking gender-affirming hormone therapy. This perspectives article speaks to the psychosocial challenges that patients with NF1 may face due to the visible signs and symptoms of their disease. The theoretical role that hormones may play in the development of cutaneous neurofibromas is also addressed.<\/jats:p>","DOI":"10.1093\/bjd\/ljae170","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T03:46:12Z","timestamp":1716781572000},"page":"285-286","source":"Crossref","is-referenced-by-count":1,"title":["Living in my own skin: dermatological concerns and gender-affirming care as a trans person with neurofibromatosis type 1"],"prefix":"10.1093","volume":"191","author":[{"given":"Alex","family":"Barbieri","sequence":"first","affiliation":[{"name":"Patient"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6492-7273","authenticated-orcid":false,"given":"Jeremy","family":"Orloff","sequence":"additional","affiliation":[{"name":"Departments of Dermatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Gulati","sequence":"additional","affiliation":[{"name":"Departments of Dermatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca M","family":"Brown","sequence":"additional","affiliation":[{"name":"Departments of Dermatology"},{"name":"Neurology, Icahn School of Medicine at Mount Sinai , New York, NY , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,5,27]]},"reference":[{"key":"2024071611292741000_ljae170-B1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/cge.12551","article-title":"Depression among adults with neurofibromatosis type 1: prevalence and impact on quality of life","volume":"88","author":"Cohen","year":"2015","journal-title":"Clin Genet"},{"key":"2024071611292741000_ljae170-B2","doi-asserted-by":"crossref","first-page":"883019","DOI":"10.3389\/fpsyg.2022.883019","article-title":"Sexual self-esteem and psychological burden of adults with neurofibromatosis type 1","volume":"13","author":"Leidger","year":"2022","journal-title":"Front Psychol"},{"key":"2024071611292741000_ljae170-B3","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15102770","article-title":"Dermatologic manifestations of neurofibromatosis type 1 and emerging treatments","volume":"15","author":"Poplausky","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2024071611292741000_ljae170-B4","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000534270","article-title":"Treatment of cutaneous neurofibromas in patients with neurofibromatosis type 1","volume":"15","author":"Wozniak","year":"2023","journal-title":"Case Rep Dermatol"},{"key":"2024071611292741000_ljae170-B5","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jaad.2023.11.058","article-title":"Noninvasive treatment of cutaneous neurofibromas (cNFs): results of a randomized prospective, direct comparison of four methods","volume":"90","author":"Richey","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"2024071611292741000_ljae170-B6","doi-asserted-by":"crossref","first-page":"e128881","DOI":"10.1172\/jci.insight.128881","article-title":"Robust surgical approach for cutaneous neurofibroma in neurofibromatosis type 1","volume":"5","author":"Chamseddin","year":"2019","journal-title":"JCI Insight"},{"issue":"2 Suppl. 1","key":"2024071611292741000_ljae170-B7","first-page":"S14","article-title":"The biology of cutaneous neurofibromas: consensus recommendations for setting research priorities","volume":"91","author":"Brosseau","year":"2018","journal-title":"Neurology"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljae170\/57914145\/ljae170.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/191\/2\/285\/58554345\/ljae170.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/191\/2\/285\/58554345\/ljae170.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T11:35:13Z","timestamp":1721129713000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/191\/2\/285\/7682272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,27]]},"references-count":7,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,5,27]]},"published-print":{"date-parts":[[2024,7,16]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljae170","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"type":"print","value":"0007-0963"},{"type":"electronic","value":"1365-2133"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,5,27]]}}}